Journal ArticleOPEN ACCESS

CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies

Cell Reports (2019) 29(11) 3405-3420.e5
DOI: 10.1016/j.celrep.2019.11.008
178Citations
Citations of this article
153Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The functional significance of lipid metabolism in cancer cells is not fully understood. Feng et al. show that the fatty acid transporter CD36 is essential for survival of breast cancer cells during anti-HER2 therapy, highlighting the role of lipid metabolism in acquired resistance to targeted therapy.

Author supplied keywords

Cite

CITATION STYLE

APA

Feng, W. W., Wilkins, O., Bang, S., Ung, M., Li, J., An, J., … Kurokawa, M. (2019). CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies. Cell Reports, 29(11), 3405-3420.e5. https://doi.org/10.1016/j.celrep.2019.11.008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free